Verbatim response from Perplexity
Zepbound generally works better for weight loss, while Wegovy is often easier to get online because it has broader availability through telehealth and more online prescribing pathways, though supply, insurance, and state rules still matter.[1][2][4][8]
-
Which works better: Head-to-head trial data consistently show more weight loss with Zepbound than Wegovy. One large comparison found average weight loss of about 20.2% with Zepbound vs 13.7% with Wegovy over 72 weeks.[1][2][6]
-
Why Zepbound may work better: Zepbound (tirzepatide) acts on two hormone pathways (GLP-1 and GIP), while Wegovy (semaglutide) acts on one; this is the main reason sources give for Zepbound’s stronger average results.[2][8][10]
-
Wegovy’s strengths: Wegovy has a longer track record and more established evidence for cardiovascular benefit, which can make it the better choice for some people even if it causes less average weight loss.[3][4][10]
-
Which is easier to get online: In practice, Wegovy is often easier to find through online clinics/pharmacies, but not always easier to obtain overall because availability changes with shortages and insurance coverage. Zepbound can be easier for some patients if their insurance covers it better, but it can also be harder to source when demand is high.[3][4][5]
-
Online convenience: Both are weekly injections and are commonly prescribed via telehealth, but neither should be considered “easy” if your insurer requires prior authorization or if your preferred dose is out of stock.[4][10]
If you want the shortest practical answer: pick Zepbound if maximum weight loss is the priority; pick Wegovy if you want a well-established option that may be simpler to access online in some markets.[1][3][4]
If you want, I can also compare price, insurance approval, side effects, and online pharmacy availability side by side.